Lung Injury from Military Deployment
Trial Objectives
The purpose of this study is to learn more about lung disease found in contractors and U.S. military personnel serving in Iraq and Afghanistan after September 11, 2001. The information collected with be used to learn about respiratory diseases associated with the inhalation of very small particulate matter and other harmful substances during deployment.
Who Can Participate
Patients who have been seen at National Jewish Health for evaluation ofrespiratory symptoms and have been deployed during military operations inSouthwest Asia and/or Afghanistan.
Age: 18-70 Gender: Any
Estimated Time Commitment
1 to 2 visits
Payment & Reimbursement
Payment: Not Provided
Travel Reimbursement: Not Available
Trial Contact
For more information, contact:
Kathy Pang
303.398.1418
Tayla Lange
720.945.8642
Nicholas Barker
303.270.2634
Trial Location
National Jewish Main Campus, Denver, CO
Payments are intended to compensate the participant for their time and effort during the study. Payments are typically given to the participant at the end of each completed study visit.
Reimbursements are intended to compensate the participant for travel-related expenses. They must be approved by the study staff and require you to turn in receipts. Travel reimbursement will vary from study to study.
Principal Investigators
Gregory P. Downey, MD, FRCPC
Co-Investigators
-
Hong Wei Chu, MD
-
Brian J. Day, PhD
-
Cecile S. Rose, MD, MPH
-
Max Seibold, PhD
Request more Information
By completing this form, you agree to learn more about this study and see if you qualify.